Do you want to read an article? Please log in or register.
Efficacy and Safety of Peppermint Oil in a Randomized Double-blind Trial of Patients With Irritable Bowel Syndrome
Irritable Bowel Syndrome (IBS) and Chronic Constipation
Related content
Irritable Bowel Syndrome (IBS) and Chronic Constipation
Efficacy of Auricular Neurostimulation in Adolescents With Irritable Bowel Syndrome in a Randomized, Double-Blind Trial
Clin Gastroenterol Hepatol.
Krasaelap A, Sood M, Li BUK, Unteutsch R, Yan K, Nugent M, Simpson P,
Kovacic K
doi: 10.1016/j.cgh.2019.10.012.
Irritable Bowel Syndrome (IBS) and Chronic Constipation
Efficacy and Safety of 5-HT4 Receptor Agonist Minesapride for Irritable Bowel Syndrome with Constipation in a Randomized Controlled Trial
Clin Gastroenterol Hepatol.
Fukudo S, Nakamura M, Hamatani T, Kazumori K, Miwa H
doi: 10.1016/j.cgh.2020.03.019.
Irritable Bowel Syndrome (IBS) and Chronic Constipation
Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study
Gut.
El-Salhy M, Hatlebakk JG, Gilja OH, Bråthen Kristoffersen A, Hausken T
doi: 10.1136/gutjnl-2019-319630.
RECOMMENDED
Irritable Bowel Syndrome (IBS) and Chronic Constipation
Efficacy of Tenapanor in Treating Patients With Irritable Bowel Syndrome With Constipation: A 12-Week, Placebo-Controlled Phase 3 Trial (T3MPO-1)
★ 1
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
Am J Gastroenterol.
Chey WD, Lembo AJ, Rosenbaum DP
doi: 10.14309/ajg.0000000000000516.
RECOMMENDED
Irritable Bowel Syndrome (IBS) and Chronic Constipation
Heat-inactivated Bifidobacterium bifidum MIMBb75 (SYN-HI-001) in the treatment of irritable bowel syndrome: a multicentre, randomised, double-blind, placebo-controlled clinical trial
★ 2
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
doi: 10.1016/S2468-1253(20)30056-X.
Irritable Bowel Syndrome (IBS) and Chronic Constipation
Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial
Lancet Gastroenterol Hepatol.
Aroniadis OC, Brandt LJ, Oneto C, Feuerstadt P, Sherman A, Wolkoff AW, Kassam Z, Sadovsky RG, Elliott RJ, Budree S, Kim M, Keller MJ
doi: 10.1016/S2468-1253
Gastroesophageal Reflux Disease (GERD)
Randomized clinical trial: a double-blind, placebo-controlled study to assess the clinical efficacy and safety of alginate-antacid (Gaviscon Double Action) chewable tablets in patients with gastro-oesophageal reflux disease
Eur J Gastroenterol Hepatol.
Wilkinson J, Wade A, Thomas SJ, Jenner B, Hodgkinson V, Coyle C
doi: 10.1097/MEG.
Irritable Bowel Syndrome (IBS) and Chronic Constipation
Efficacy and safety of Gelsectan for diarrhoea-predominant irritable bowel syndrome: A randomised, crossover clinical trial
United European Gastroenterol J.
Trifan A, Burta O, Tiuca N, Petrisor DC, Lenghel A, Santos J
doi: 10.1177/2050640619862721.
Irritable Bowel Syndrome (IBS) and Chronic Constipation
Irritable Bowel Syndrome (IBS) and Chronic Constipation Long-term treatment with plecanatide was safe and tolerable in patients with irritable bowel syndrome with constipation
Curr Med Res Opin.
Barish CF, Crozier RA, Griffin P
doi: 10.1080/03007995.